GemPharmatech will attend the 20th Transgenic Technologies Meeting in Leiden, the Netherlands from September 15 to 18, 2026.
Published
Signal category
Presence & Recognition
Quote
“GemPharmatech will be attending the 20th Transgenic Technologies Meeting (#TT2026), taking place September 15 – 18, 2026 in Leiden, the Netherlands.”
— GemPharmatech team
Company
GemPharmatech
Accelerating Innovation Through Genetically Engineered Mouse Models (GEMMs) and Preclinical Services
- Industry
- Biotechnology Research
- Location
- San Diego, US
- Company size
- 110 employees
GemPharmatech Co. Ltd., founded in 2017, is an international biotechnology enterprise specializing in the development of humanized animal models. The management and operation team has nearly 20 years of experience in gene-editing technology and animal production. GemPharmatech provides a one-stop service as model customization, breeding, phenotyping, and pharmacology for the biomedical research community. The company has developed the world's most abundant mouse strains resource to inspire scientific innovation and drive drug discovery.
Founded 2017